Skip to Content

Printing Bones in 3-D

The technology could be used by dentists and orthopedists to create custom implants that encourage growth of new bone.
December 1, 2011

Researchers at Washington State University tweaked a commercial 3-D printer to create three-dimensional structures made from a bone-like material. When incubated in the lab with immature bone cells, the printed bone helped support growth of a new network of bone cells. Preliminary tests in rats and rabbits also look promising, according to lead scientist Susmita Bose, co-author and professor in WSU’s School of Mechanical and Materials Engineering.

Researchers customized a commercial 3-D printer to create scaffolds of a bone-like material. Credit: WSU

It’s possible that doctors will be able to custom order replacement bone tissue in a few years, said Bose, in a release from the university. “If a doctor has a CT scan of a defect, we can convert it to a CAD file and make the scaffold according to the defect,” Bose said.

To create the scaffolds, researchers optimized a commercially available ProMetal 3D printer designed to make metal objects. They also doubled the strength of the main building material, calcium phosphate, by adding silicon and zinc.The research was published in Dental Materials.

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.